Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Osugo

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Psychiatric Practice|January 13, 2021
Multidisciplinary Management of a Frequent Attender With Pyrexia of Unknown Origin and Psychotic SymptomsMartin Osugo, Audrey Ng
Schizophrenia Bulletin|March 21, 2026
What is Minimally Adequate Treatment of Psychosis and Should Duration of Inadequate Treatment be a Clinical and Research Target? A Perspective and State-of-the-Art ReviewMartin Osugo, Oliver D Howes
The British Journal of Psychiatry : the Journal of Mental Science|June 5, 2023
Treating negative symptoms of schizophrenia: current approaches and future perspectivesOliver Howes, Paolo Fusar-Poli, Martin Osugo
Journal of Clinical Psychopharmacology|October 23, 2024
Aripiprazole-Associated QT Prolongation in a Healthy Study Volunteer: A Case Report and Literature ReviewGeorge E Chapman, Martin Osugo, Antonio de Marvao, et al.
Neuroscience and Biobehavioral Reviews|February 8, 2022
Dopamine partial agonists and prodopaminergic drugs for schizophrenia: Systematic review and meta-analysis of randomized controlled trialsMartin Osugo, Thomas Whitehurst, Ekaterina Shatalina, et al.
Neuroscience and Biobehavioral Reviews|October 17, 2020
Proton Magnetic Resonance Spectroscopy of N-acetyl Aspartate in Chronic Schizophrenia, First Episode of Psychosis and High-Risk of Psychosis: A Systematic Review and Meta-AnalysisThomas Samuel Whitehurst, Martin Osugo, Leigh Townsend, et al.
Molecular Psychiatry|May 13, 2022
The relationship between glutamate, dopamine, and cortical gray matter: A simultaneous PET-MR studyAntoine Rogeau, Giovanna Nordio, Mattia Veronese, et al.
Science Advances|June 10, 2021
Dopaminergic organization of striatum is linked to cortical activity and brain expression of genes associated with psychiatric illnessRobert A McCutcheon, Kirsten Brown, Matthew M Nour, et al.
Frontiers in Psychiatry|March 18, 2024
Corrigendum: The effect of antipsychotics on glutamate levels in the anterior cingulate cortex and clinical response: a <sup>1</sup>H-MRS study in first-episode psychosis patientsUzma Zahid, Robert A McCutcheon, Faith Borgan, et al.
Frontiers in Psychiatry|August 29, 2022
The effect of antipsychotics on glutamate levels in the anterior cingulate cortex and clinical response: A <sup>1</sup>H-MRS study in first-episode psychosis patientsUzma Zahid, Robert A McCutcheon, Faith Borgan, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Psychiatric Practice|January 13, 2021
Multidisciplinary Management of a Frequent Attender With Pyrexia of Unknown Origin and Psychotic SymptomsMartin Osugo, Audrey Ng
Schizophrenia Bulletin|March 21, 2026
What is Minimally Adequate Treatment of Psychosis and Should Duration of Inadequate Treatment be a Clinical and Research Target? A Perspective and State-of-the-Art ReviewMartin Osugo, Oliver D Howes
The British Journal of Psychiatry : the Journal of Mental Science|June 5, 2023
Treating negative symptoms of schizophrenia: current approaches and future perspectivesOliver Howes, Paolo Fusar-Poli, Martin Osugo
Journal of Clinical Psychopharmacology|October 23, 2024
Aripiprazole-Associated QT Prolongation in a Healthy Study Volunteer: A Case Report and Literature ReviewGeorge E Chapman, Martin Osugo, Antonio de Marvao, et al.
Neuroscience and Biobehavioral Reviews|February 8, 2022
Dopamine partial agonists and prodopaminergic drugs for schizophrenia: Systematic review and meta-analysis of randomized controlled trialsMartin Osugo, Thomas Whitehurst, Ekaterina Shatalina, et al.
Neuroscience and Biobehavioral Reviews|October 17, 2020
Proton Magnetic Resonance Spectroscopy of N-acetyl Aspartate in Chronic Schizophrenia, First Episode of Psychosis and High-Risk of Psychosis: A Systematic Review and Meta-AnalysisThomas Samuel Whitehurst, Martin Osugo, Leigh Townsend, et al.
Molecular Psychiatry|May 13, 2022
The relationship between glutamate, dopamine, and cortical gray matter: A simultaneous PET-MR studyAntoine Rogeau, Giovanna Nordio, Mattia Veronese, et al.
Science Advances|June 10, 2021
Dopaminergic organization of striatum is linked to cortical activity and brain expression of genes associated with psychiatric illnessRobert A McCutcheon, Kirsten Brown, Matthew M Nour, et al.
Frontiers in Psychiatry|March 18, 2024
Corrigendum: The effect of antipsychotics on glutamate levels in the anterior cingulate cortex and clinical response: a <sup>1</sup>H-MRS study in first-episode psychosis patientsUzma Zahid, Robert A McCutcheon, Faith Borgan, et al.
Frontiers in Psychiatry|August 29, 2022
The effect of antipsychotics on glutamate levels in the anterior cingulate cortex and clinical response: A <sup>1</sup>H-MRS study in first-episode psychosis patientsUzma Zahid, Robert A McCutcheon, Faith Borgan, et al.
Pageof 3